This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Automated High-Quality Insights
Meet Galen™, the most widely-deployed AI-powered platform in pathology.
Developed by pathologists for pathologists, Galen is a clinical-grade, multi-tissue platform that helps pathologists detect and grade breast, prostate and gastric cancer, along with more than a hundred other clinically relevant features.
Seamlessly integrated with third party digital pathology software solutions, scanning platforms and laboratory information systems, Galen’s AI-enabled workflows deliver automated high-quality insights that enhance patient safety, increase physician confidence and boost productivity.
Galen serves the world’s leading physicians, health systems and diagnostic service providers. The platform has demonstrated outstanding outcomes in rigorous worldwide clinical studies on multiple scanning systems and staining platforms.
Pathologists
- Enhanced diagnostic quality
- Faster results
- Better patient outcomes
- Greater confidence
- Lower workload
- Streamlined work experience
Patients
- Improved diagnostic quality
- Faster results
- Better clinical outcomes
- Greater confidence
Providers
- Better patient outcomes
- Higher productivity
- More efficient workflows
- Improved service quality
- Greater physician satisfaction
- Innovative positioning
Industry Partners
- The broadest AI platform
- Field-proven technology
- Validated performance
- Open API for seamless integration
Articles
Ibex’s Chief Scientific Officer on AI-powered cancer diagnostics, company raising $38 Million in series B funding and the future of personalized medicine
Multiple solutions under the Galen™ platform are CE marked (IVDD) and registered with the UK MHRA and ANVISA in Brazil. Galen First Read for prostate is also CE marked under IVDR. The Galen platform includes solutions which are for Research Use Only (RUO) in the United States and not cleared by the FDA. Contact us for more information, including indication for use and regulatory approval in other countries.